Chemical ID |
Chemical Name |
Interaction |
Interaction Action |
Publication |
---|
C006632 |
arsenic trioxide |
arsenic trioxide results in increased expression of MYO6 mRNA | increases expression | 17258074
|
C053541 |
bicalutamide |
bicalutamide results in increased expression of MYO6 mRNA | increases expression | 15790403 16631469
|
D003010 |
Clorgyline |
Clorgyline results in increased expression of MYO6 mRNA | increases expression | 19691856
|
D005038 |
Ethylnitrosourea |
Ethylnitrosourea results in increased mutagenesis of MYO6 gene | increases mutagenesis | 17329413
|
D005472 |
Fluorouracil |
MYO6 protein affects the susceptibility to Fluorouracil | affects response to substance | 16217747
|
D008727 |
Methotrexate |
MYO6 protein affects the susceptibility to Methotrexate | affects response to substance | 16217747
|
D012643 |
Selenium |
[Selenium co-treated with Vitamin E] results in decreased expression of MYO6 mRNA | affects cotreatment|decreases expression | 19244175
|
D012643 |
Selenium |
Selenium results in decreased expression of MYO6 mRNA | decreases expression | 19244175
|
D014635 |
Valproic Acid |
Valproic Acid results in increased expression of MYO6 mRNA | increases expression | 19101580
|
D014810 |
Vitamin E |
[Selenium co-treated with Vitamin E] results in decreased expression of MYO6 mRNA | affects cotreatment|decreases expression | 19244175
|
D014810 |
Vitamin E |
Vitamin E results in decreased expression of MYO6 mRNA | decreases expression | 19244175
|
Disease ID |
Disease Name |
Direct Evidence |
Inference Chemical Name |
Inference Score |
Publication |
---|
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Methotrexate |
9.79 | 12039119 |
MESH:D000014 |
Abnormalities, Drug-Induced |
|
Valproic Acid |
9.79 | 8875741 |
MESH:D000015 |
Abnormalities, Multiple |
|
Valproic Acid |
4.13 | 19490988 |
MESH:D000230 |
Adenocarcinoma |
|
arsenic trioxide |
4.66 | 19825857 11798837 |
MESH:D000230 |
Adenocarcinoma |
|
Fluorouracil |
4.66 | 17638652 |
MESH:D000236 |
Adenoma |
|
Ethylnitrosourea |
3.83 | 6695378 |
MESH:D000550 |
Amblyopia |
|
Valproic Acid |
5.55 | 17688650 |
MESH:D000740 |
Anemia |
|
Fluorouracil |
3.90 | 17963324 16511603 15504547 |
MESH:D001008 |
Anxiety Disorders |
|
Valproic Acid |
3.74 | 17497229 |
MESH:D001172 |
Arthritis, Rheumatoid |
|
Methotrexate |
3.14 | 17286800 |
MESH:D001321 |
Autistic Disorder |
|
Valproic Acid |
1.99 | 17507914 18396377 15238991 18940202 18985861 17157402 18316065 18775368 20603192 19460635 18558336 16609825 19232924 17688650 18177632 |
MESH:D001714 |
Bipolar Disorder |
|
Valproic Acid |
3.17 | 17594078 20046352 |
MESH:D001778 |
Blood Coagulation Disorders |
|
arsenic trioxide |
3.88 | 16206674 |
MESH:D001848 |
Bone Diseases, Developmental |
|
Valproic Acid |
3.52 | 8888407 |
MESH:D001927 |
Brain Diseases |
|
Ethylnitrosourea |
5.07 | 14991843 |
MESH:D001932 |
Brain Neoplasms |
|
Ethylnitrosourea |
4.48 | 18412241 16436596 16651633 16357521 15144691 |
MESH:D001943 |
Breast Neoplasms |
|
Fluorouracil |
2.55 | 19217205 18357371 16557594 15136595 16110121 16595493 18608205 |
MESH:D001943 |
Breast Neoplasms |
|
Methotrexate |
2.55 | 16978400 |
MESH:D002051 |
Burkitt Lymphoma |
|
arsenic trioxide |
4.55 | 11589617 |
MESH:D002252 |
Carbon Tetrachloride Poisoning |
|
Vitamin E |
4.19 | 16050911 |
MESH:D002276 |
Carcinoid Tumor |
|
Fluorouracil |
4.99 | 16051944 |
MESH:D002277 |
Carcinoma |
|
Fluorouracil |
3.73 | 17121937 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
arsenic trioxide |
3.23 | 15073043 16217749 11135700 14691202 15553829 |
MESH:D006528 |
Carcinoma, Hepatocellular |
|
Fluorouracil |
3.23 | 16799960 16332177 18930000 17971768 17088986 17045692 |
MESH:D002291 |
Carcinoma, Papillary |
|
arsenic trioxide |
5.19 | 19014326 |
MESH:D002292 |
Carcinoma, Renal Cell |
|
Fluorouracil |
3.10 | 18695887 |
MESH:D018288 |
Carcinoma, Small Cell |
|
arsenic trioxide |
4.31 | 12490120 |
MESH:D002294 |
Carcinoma, Squamous Cell |
|
Fluorouracil |
2.54 | 18986760 17066447 16280240 16757204 |
MESH:D002471 |
Cell Transformation, Neoplastic |
|
Ethylnitrosourea |
3.86 | 16003739 |
MESH:D016543 |
Central Nervous System Neoplasms |
|
Ethylnitrosourea |
6.30 | 17160924 |
MESH:D002659 |
Child Development Disorders, Pervasive |
|
Valproic Acid |
2.77 | 20734317 |
MESH:D003092 |
Colitis |
|
Selenium |
4.04 | 17936198 |
MESH:D003110 |
Colonic Neoplasms |
|
Fluorouracil |
2.26 | 17725105 17169374 16510598 18772588 15001691 17287894 17016597 16340194 17172411 17018589 |
MESH:D015179 |
Colorectal Neoplasms |
|
arsenic trioxide |
2.59 | 20501625 |
MESH:D015179 |
Colorectal Neoplasms |
|
Fluorouracil |
2.59 | 20501625 17016601 17401013 14970324 17695437 16391804 18802399 17255274 16303861 18288408 18509181 17094418 16282729 18448328 18383874 15289873 17454858 18949393 15148649 17594712 16524972 16331619 |
MESH:D023903 |
Coronary Restenosis |
|
arsenic trioxide |
4.42 | 12609071 |
MESH:D019465 |
Craniofacial Abnormalities |
|
arsenic trioxide |
5.63 | 10525206 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Methotrexate |
5.63 | 9562676 12039119 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Valproic Acid |
5.63 | 8888407 16575769 17688650 |
MESH:D019465 |
Craniofacial Abnormalities |
|
Vitamin E |
5.63 | 19769572 |
MESH:D003550 |
Cystic Fibrosis |
|
Methotrexate |
4.43 | 19747007 |
MESH:D007644 |
Darier Disease |
|
Fluorouracil |
5.08 | 16733453 |
OMIM:606346 |
DEAFNESS, AUTOSOMAL DOMINANT 22;DFNA22 DEAFNESS, AUTOSOMAL DOMINANT 22, WITH HYPERTROPHIC CARDIOMYOPATHY, |
marker/mechanism |
|
| |
OMIM:607821 |
DEAFNESS, AUTOSOMAL RECESSIVE 37 |
marker/mechanism |
|
| |
MESH:D016757 |
Death, Sudden, Cardiac |
|
arsenic trioxide |
4.32 | 15213294 |
MESH:D003882 |
Dermatomyositis |
|
Methotrexate |
5.36 | 20191521 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Selenium |
4.18 | 15131321 |
MESH:D056486 |
Drug-Induced Liver Injury |
|
Valproic Acid |
4.18 | 1733752 19641884 |
MESH:D004421 |
Dystonia |
|
Valproic Acid |
4.27 | 1851702 |
MESH:C538011 |
Eales disease |
|
Vitamin E |
5.02 | 9068938 |
MESH:D004476 |
Ectodermal Dysplasia |
|
Ethylnitrosourea |
6.30 | 18357618 |
MESH:D004831 |
Epilepsies, Myoclonic |
|
Valproic Acid |
4.41 | 3659116 17275665 |
MESH:D004828 |
Epilepsies, Partial |
|
Valproic Acid |
4.23 | 16628512 3922381 |
MESH:D004827 |
Epilepsy |
|
Valproic Acid |
3.03 | 18234410 20417680 |
MESH:D004832 |
Epilepsy, Absence |
|
Valproic Acid |
3.77 | 7562514 6426943 6254150 |
MESH:D017029 |
Epilepsy, Complex Partial |
|
Valproic Acid |
4.56 | 7750514 |
MESH:D004830 |
Epilepsy, Tonic-Clonic |
|
Valproic Acid |
4.35 | 3659116 |
MESH:D004938 |
Esophageal Neoplasms |
|
arsenic trioxide |
4.75 | 12903497 |
MESH:D004938 |
Esophageal Neoplasms |
|
Fluorouracil |
4.75 | 16785472 16337965 16481741 15173087 17638652 |
MESH:D005234 |
Fatty Liver |
|
arsenic trioxide |
8.61 | 15073043 |
MESH:D005234 |
Fatty Liver |
|
Valproic Acid |
8.61 | 19224547 14986274 |
MESH:D005315 |
Fetal Diseases |
|
Valproic Acid |
5.20 | 16575769 |
MESH:D005317 |
Fetal Growth Retardation |
|
Valproic Acid |
4.37 | 8888407 18558336 |
MESH:D005706 |
Gallbladder Neoplasms |
|
arsenic trioxide |
4.50 | 16904648 |
MESH:D005909 |
Glioblastoma |
|
Ethylnitrosourea |
3.95 | 16436596 |
MESH:D005910 |
Glioma |
|
Ethylnitrosourea |
6.58 | 16357521 18412241 16651633 |
MESH:D005910 |
Glioma |
|
Fluorouracil |
6.58 | 16145905 |
MESH:D006086 |
Graft vs Host Disease |
|
Methotrexate |
5.41 | 16518429 |
MESH:D006258 |
Head and Neck Neoplasms |
|
Fluorouracil |
3.52 | 18337622 15162350 15102660 |
MESH:D006330 |
Heart Defects, Congenital |
|
Vitamin E |
3.08 | 16080930 |
MESH:D006333 |
Heart Failure |
|
Selenium |
3.19 | 17162251 |
MESH:D006548 |
Hernia, Diaphragmatic |
|
Vitamin E |
2.76 | 16490937 16863852 |
MESH:D019584 |
Hot Flashes |
|
Vitamin E |
4.29 | 14716179 |
MESH:D006849 |
Hydrocephalus |
|
Valproic Acid |
5.15 | 17688650 |
MESH:D007251 |
Influenza, Human |
|
Selenium |
12.04 | 16624496 |
MESH:D007251 |
Influenza, Human |
|
Vitamin E |
12.04 | 16624496 |
MESH:D007674 |
Kidney Diseases |
|
Vitamin E |
2.91 | 12488133 |
MESH:D007676 |
Kidney Failure, Chronic |
|
Selenium |
4.09 | 16518626 |
MESH:D007680 |
Kidney Neoplasms |
|
Ethylnitrosourea |
8.41 | 17379185 |
MESH:D007680 |
Kidney Neoplasms |
|
Fluorouracil |
8.41 | 16985049 |
MESH:D007805 |
Language Development Disorders |
|
Methotrexate |
5.32 | 9562676 |
MESH:D007938 |
Leukemia |
|
arsenic trioxide |
2.92 | 15070760 |
MESH:D015459 |
Leukemia-Lymphoma, Adult T-Cell |
|
arsenic trioxide |
4.00 | 17077332 12560223 |
MESH:D007948 |
Leukemia, Monocytic, Acute |
|
arsenic trioxide |
4.59 | 16972261 |
MESH:D015464 |
Leukemia, Myelogenous, Chronic, BCR-ABL Positive |
|
arsenic trioxide |
3.58 | 14633726 |
MESH:D007951 |
Leukemia, Myeloid |
|
arsenic trioxide |
3.97 | 19077051 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
arsenic trioxide |
4.01 | 19850784 17050201 16467208 16968895 20471514 |
MESH:D015470 |
Leukemia, Myeloid, Acute |
|
Valproic Acid |
4.01 | 17596541 16294345 |
MESH:D015473 |
Leukemia, Promyelocytic, Acute |
|
arsenic trioxide |
3.34 | 16966277 17107899 17869043 19642359 19225113 17649720 12679006 17712046 16331271 16823087 15622746 11468182 15748426 19035177 11161223 19075265 16330433 16891316 15336539 9834237 16112521 12712474 15213294 12018890 17217047 |
MESH:D015458 |
Leukemia, T-Cell |
|
arsenic trioxide |
4.59 | 16882451 |
MESH:D008103 |
Liver Cirrhosis |
|
Methotrexate |
3.80 | 14986274 |
MESH:D008106 |
Liver Cirrhosis, Experimental |
|
Vitamin E |
1.90 | 16169303 |
MESH:D008113 |
Liver Neoplasms |
|
arsenic trioxide |
4.94 | 14682389 |
MESH:D008113 |
Liver Neoplasms |
|
Fluorouracil |
4.94 | 16603448 18383874 17045692 15113037 |
MESH:D008114 |
Liver Neoplasms, Experimental |
|
arsenic trioxide |
2.85 | 20377131 |
MESH:D008133 |
Long QT Syndrome |
|
arsenic trioxide |
3.51 | 15213294 |
MESH:D008171 |
Lung Diseases |
|
Vitamin E |
3.31 | 16863852 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Methotrexate |
12.55 | 18516814 |
MESH:D017563 |
Lung Diseases, Interstitial |
|
Valproic Acid |
12.55 | 17228818 |
MESH:D008175 |
Lung Neoplasms |
|
arsenic trioxide |
5.09 | 11798837 19825857 |
MESH:D008175 |
Lung Neoplasms |
|
Ethylnitrosourea |
5.09 | 16271038 17703301 16019985 6695378 |
MESH:D008175 |
Lung Neoplasms |
|
Fluorouracil |
5.09 | 15246190 |
MESH:D008175 |
Lung Neoplasms |
|
Vitamin E |
5.09 | 11062179 |
MESH:D008178 |
Lupus Erythematosus, Cutaneous |
|
Fluorouracil |
5.08 | 15086387 |
MESH:D008223 |
Lymphoma |
|
Ethylnitrosourea |
8.58 | 15790496 |
MESH:D008223 |
Lymphoma |
|
Methotrexate |
8.58 | 17352296 |
MESH:D016399 |
Lymphoma, T-Cell |
|
Ethylnitrosourea |
5.31 | 15375218 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Ethylnitrosourea |
6.79 | 10767621 10838139 18041768 |
MESH:D008325 |
Mammary Neoplasms, Experimental |
|
Selenium |
6.79 | 15318939 |
MESH:D008579 |
Meningioma |
|
Ethylnitrosourea |
6.30 | 17943659 |
MESH:D008654 |
Mesothelioma |
|
Selenium |
2.86 | 15107826 |
MESH:D008881 |
Migraine Disorders |
|
Valproic Acid |
3.33 | 18765137 18803445 |
MESH:D009062 |
Mouth Neoplasms |
|
Fluorouracil |
3.79 | 16757204 18986760 |
MESH:D052016 |
Mucositis |
|
Methotrexate |
5.57 | 17488658 |
MESH:D009101 |
Multiple Myeloma |
|
arsenic trioxide |
3.25 | 19549372 19417148 15949261 14977855 11468182 |
MESH:D009139 |
Musculoskeletal Abnormalities |
|
Valproic Acid |
4.23 | 8888407 |
MESH:D009182 |
Mycosis Fungoides |
|
arsenic trioxide |
4.99 | 18349030 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
arsenic trioxide |
7.78 | 16105982 16882451 |
MESH:D009190 |
Myelodysplastic Syndromes |
|
Valproic Acid |
7.78 | 17596541 |
MESH:D009361 |
Neoplasm Invasiveness |
|
arsenic trioxide |
4.20 | 16624393 |
MESH:D009369 |
Neoplasms |
|
Fluorouracil |
2.70 | 18239605 18600527 16928823 |
MESH:D009374 |
Neoplasms, Experimental |
|
Ethylnitrosourea |
4.66 | 16707424 |
MESH:D009436 |
Neural Tube Defects |
|
arsenic trioxide |
7.75 | 10525206 |
MESH:D009436 |
Neural Tube Defects |
|
Valproic Acid |
7.75 | 16359493 8888407 |
MESH:D009442 |
Neurilemmoma |
|
Ethylnitrosourea |
5.70 | 17160924 16003739 16651423 |
MESH:D020258 |
Neurotoxicity Syndromes |
|
Fluorouracil |
3.57 | 16436463 |
MESH:D009837 |
Oligodendroglioma |
|
Ethylnitrosourea |
6.30 | 17160924 |
MESH:D010051 |
Ovarian Neoplasms |
|
arsenic trioxide |
2.46 | 19769630 12452020 16624393 |
MESH:D010190 |
Pancreatic Neoplasms |
|
arsenic trioxide |
5.57 | 15580305 |
MESH:D010190 |
Pancreatic Neoplasms |
|
Fluorouracil |
5.57 | 16929163 19003803 16500647 15113037 |
MESH:D010235 |
Paraganglioma |
|
arsenic trioxide |
4.38 | 19927285 |
MESH:D010954 |
Plasmacytoma |
|
Selenium |
5.21 | 15087411 |
MESH:D011297 |
Prenatal Exposure Delayed Effects |
|
Valproic Acid |
4.11 | 20603192 |
MESH:D011471 |
Prostatic Neoplasms |
|
arsenic trioxide |
1.89 | 19131511 |
MESH:D011471 |
Prostatic Neoplasms |
|
bicalutamide |
1.89 | 15638997 18487222 19240160 19011039 17914592 |
MESH:D011471 |
Prostatic Neoplasms |
|
Clorgyline |
1.89 | 19691856 |
MESH:D011471 |
Prostatic Neoplasms |
|
Fluorouracil |
1.89 | 18626508 19082440 |
MESH:D011471 |
Prostatic Neoplasms |
|
Vitamin E |
1.89 | 15084515 |
MESH:D019310 |
Pseudolymphoma |
|
Valproic Acid |
4.86 | 12752131 11422049 |
MESH:D011565 |
Psoriasis |
|
Methotrexate |
3.49 | 17410198 |
MESH:D012004 |
Rectal Neoplasms |
|
Fluorouracil |
4.19 | 16160472 18286688 18722050 15538739 |
MESH:D051437 |
Renal Insufficiency |
|
Methotrexate |
4.97 | 17352296 |
MESH:D012208 |
Rhabdomyosarcoma |
|
Valproic Acid |
4.40 | 19155313 |
MESH:D012512 |
Sarcoma, Ewing's |
|
arsenic trioxide |
4.20 | 16646077 |
MESH:D012559 |
Schizophrenia |
|
Valproic Acid |
2.09 | 15737665 19110320 |
MESH:D012640 |
Seizures |
|
Valproic Acid |
2.87 | 14763951 15475178 16876388 3137016 11738929 1511512 17978042 11044598 |
MESH:D012871 |
Skin Diseases |
|
Vitamin E |
2.48 | 18709164 |
MESH:D016135 |
Spinal Dysraphism |
|
Valproic Acid |
3.94 | 19490988 |
MESH:D013226 |
Status Epilepticus |
|
Valproic Acid |
4.86 | 12833885 |
MESH:D013274 |
Stomach Neoplasms |
|
arsenic trioxide |
2.57 | 17007042 |
MESH:D013274 |
Stomach Neoplasms |
|
Fluorouracil |
2.57 | 16951190 18396642 15786421 17522103 19015929 16424979 19084572 17498489 18567086 17172411 |
MESH:D020521 |
Stroke |
|
Vitamin E |
3.68 | 16517955 |
MESH:D013576 |
Syndactyly |
|
Methotrexate |
5.27 | 9562676 |
MESH:D013953 |
Thymus Neoplasms |
|
Ethylnitrosourea |
5.45 | 15790496 |
MESH:D013964 |
Thyroid Neoplasms |
|
arsenic trioxide |
3.24 | 19014326 |
MESH:D014062 |
Tongue Neoplasms |
|
Fluorouracil |
4.18 | 16280240 |
MESH:D016171 |
Torsades de Pointes |
|
arsenic trioxide |
4.24 | 15213294 |
MESH:D014178 |
Translocation, Genetic |
|
Valproic Acid |
5.55 | 17262798 |
MESH:D020194 |
Unverricht-Lundborg Syndrome |
|
Valproic Acid |
4.81 | 3119515 |
MESH:D001749 |
Urinary Bladder Neoplasms |
|
arsenic trioxide |
2.55 | 11780464 20435036 12845720 12973940 |
MESH:D014564 |
Urogenital Abnormalities |
|
Valproic Acid |
4.90 | 8888407 |
MESH:D002583 |
Uterine Cervical Neoplasms |
|
Fluorouracil |
4.07 | 16803524 |